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Some skin lesions may accompany malignancies. Acanthosis nigricans, one such lesion, is a paraneoplastic dermatosis charac-
terized by hyperpigmented and velvety verrucose plaques observed as symetric eruptions. With this report, we aim to present a
rare case of concomitant lung cancer and acanthosis nigricans. Malignant acanthosis nigricans is most commonly associated with
intra-abdominal malignancies. A 65-year-old patient who had hyperpigmented, hypertrophic and symmetric verrucose lesions
at the ﬂexor surfaces of the lower and upper extremities, face, palms and the axillary region. Thoracic computed tomography
demonstrated a hypodense mass lesion with a dimension of 5 × 5.5 cm at the center of basal segment bronchi of the left
pulmonary lobe. Fiberoptic bronchoscopy showed that the access to the lower left lobe was almost completely obstructed by the
endobronchial lesion. The result of the histopathologic examination of the endobronchial tissue biopsy was reported as non-small
cell (adenocarcinoma) lung cancer. Result of the histopathologic analysis of the punch biopsy of the skin lesions was reported as
acanthosis nigricans .There are no pathognomonic dermatological ﬁndings for lung cancer. In conclusion, there are skin lesions
that accompany lung cancer and we believe that these should be considered for diﬀerential diagnosis.
1.Introduction
Some skin lesions may accompany malignancies. Acanthosis
nigricans, one such lesion, is a paraneoplastic dermatosis
characterized by hyperpigmented and velvety verrucose
plaques observed as symmetric eruptions.
It is often localized on ﬂexor surfaces such as the axilla,
posterior neck fold, anterior umbilical, and popliteal and
inguinal areas where skin folds. It may be idiopathic but may
also be associated with endocrinal disorders, malignancies,
medicines, and genetic syndromes. Besides, acanthosis nigri-
cans may also present autosomal dominant involvement [1–
3].
Malignant acanthosis nigricans is most commonly asso-
ciated with intra-abdominal malignancies. There are very
few reports in the literature of malignant acanthosis nigri-
cans associated with lung cancer.
With this report, we aim to present a rare case of con-
comitant lung cancer and acanthosis nigricans.
2. Case Presentation
A 65-year-old male patient who presented to our clinic
had the complaints of cough and phlegm for the past 10
years which particularly exacerbated in winter and shortness
of breath exacerbating with eﬀort for the past one year.
An informed consent was taken from the patient. Patient had
no comorbid disease including diabetes mellitus.
The patient also had dark-colored lesions that he ﬁrst
observed one month ago and spread to the body thereafter,
and the additional complaints of worsened shortness of
breath and weight loss. His history involved smoking, 60
boxes/year. His familial history had no relevant ﬁndings.
Physical examination revealed the following values: BP:
120/80mmHg, RR: 16/min, and temperature 36.5
◦C. The
patient had body weight: 64kg and body length: 170cm,
BMI: 22.14kg/m2.
Thepatienthadhyperpigmented,hypertrophicandsym-
metric verrucose lesions at the ﬂexor surfaces of the lower2 Case Reports in Medicine
Figure 1: Thoracic computed tomography (a hypodense mass
lesion at the left pulmonary lobe).
and upper extremities, face, palms, and the axillary region.
An examination of the respiratory tract with auscultation
revealed bilateral infrequent expiratory rhoncus. Findings
of other examinations were normal. Laboratory ﬁndings
s h o w e da nE S Rv a l u eo f6 4 m / h ,f a s t i n gb l o o dg l u c o s ea s
74mg/dl. Compensated respiratory acidosis was observed
during blood gas analysis. Other laboratory ﬁndings were
within normal ranges.
Thoracic computed tomography demonstrated a hypo-
dense mass lesion with a dimension of 5 × 5.5cm at the
center of basal segment bronchi of the left pulmonary lobe,
which did not have clear borders distinguishable from the
peripheral consolidation region (Figure 1).
Fiberoptic bronchoscopy showed that the access to the
lower left lobe was almost completely obstructed by the
endobronchial lesion.
Abdominal tomography, esophagoduodenoscopic, col-
onoscopic examination revealed no malignancies, only ero-
sive gastritis was found. Primary lesion was considered as
the primary tumor as there was no malignancy at any
organ. The result of the histopathologic examination of the
endobronchial tissue biopsy was reported as nonsmall cell
(adenocarcinoma) lung cancer (Figure 3).
Resultofthehistopathologicanalysisofthepunchbiopsy
of the skin lesions was reported as acanthosis nigricans
(Figure 4).
3. Discussion
There are no pathognomonic dermatological ﬁndings for
lung cancer. However, some skin lesions should suggest lung
cancer in diﬀerential diagnosis. Acanthosis nigricans is one
such lesion. Acanthosis nigricans may both be benign or
malign. Its benign form may be observed in association with
some endocrinal disorders, obesity, some genetic syndromes,
anddruguse(nicotinicacid,estrogen,corticosteroids)[4,5].
We could not manage to ﬁnd the actual percentage for
“idiopathic acanthosis nigricans” from the literatures, but we
consider that the most of the cases can be associated with a
disease.
(a)
(b)
Figure 2: Hyperpigmentation in the back and hands.
Figure 3: Coarse hyperchromatic atypical cell cluster with an
average-width eosinophilic cytoplasm with evident nucleolus
(H&E, x40 obj).
Malignacanthosisnigricansaccountsfor20%ofallacan-
thosis nigricans cases. It develops as a result of expression of
the transforming growth factor alpha (TGF alpha) of tumor
cells, melanocyte stimulating hormone alpha, and peptides
causing cellular proliferation including insulin-like growth
factor 1 [6].
Of the malignancies accompanying malign acanthosis
nigricans in the adult population, 45–69% are gastric ade-
nocarcinomas. Malign acanthosis nigricans is observed with
a frequency of 70–92% of all abdominal neoplasms [7–9].Case Reports in Medicine 3
Figure 4: Hyperkeratosis, papillomatous mild acanthosis in the
epidermis and hyperpigmentation at the basal layer (H& E, x20
obj).
approximately, 9% of all MAN cases are related with extra-
abdominal malignancies: Endometrium [10]l y m p h o m a
[11], mycosis fungoides, melanoma, and sarcomas [12].
These are all presented as case reports.
After diagnosing as acanthosis nigricans, benign diseases
were investigated (no diabetes, obesity, drug use such
as nicotinic acid, estrogen, or corticosteroid). After that,
possibility malign disease was thougt. The most common
form of malignancy with MAN, the abdominal malignancy
was investigated by abdominal tomography, esophagoduo-
denoscopy, colonoscopy, and rectoscopy which were all
normal. The edoscopic investigations should be done in
every patient with MAN. They all revealed normal ﬁndings
in this patient. Brain computerised tomography and bone
scintigraphy revealed no lesions. If there were no lung cancer
in our case, the other rare malignancies with MAN listed
above would have been searched.
First described by Pollitzer in 1891, acanthosis nigricans
is a key indicator of insulin resistance independent from
the body mass index [13–15]. It has an increasing incidence
in obese children and adults. It may be seen together with
other skin disorders in patients with insulin resistance and
uncontrolled diabetes [16, 17]. The patient had no diabetic
disease.
Co-occurrence of acanthosis nigricans and lung cancers
is rare. The association with bronchial carcinoma was ﬁrst
reported in 1909 [18]. Curth et al. [19]e x t e n s i v e l yr e v i e w e d
the association of pulmonary neoplasms and acanthosis
nigricans. To date, eight cases of adenocarcinoma of the
lung and ﬁve cases of squamous carcinoma of the lung
have been reported in association with acanthosis nigricans
[20]. A patient with bronchoalveoler carsinom is reported
[21]. And only few cases with pulmonary malignancy with
acanthosis nigricans are reported in the literature [22, 23].
It alone may predict malignancy or may develop with other
signs or occur later. Tumors are often in the advanced
phase even when malign acanthosis nigricans is diagnosed
simultaneously with the tumor. Since the patient had no
radiography at the early phase and his recent radiography
showed a large mass in the lung, we believe that the skin
lesions developed later. Treatment of malign acanthosis
nigricans depends on the treatment of the underlying malig-
nancy. Skin lesions usually regress as treatment success is
achieved.
No masses were detected during the scans of the other
organs. Being assessed as advanced phase nonsmall cell lung
cancer, the patient was examined by the oncology depart-
ment. Chemotherapy and radiotherapy were initiated and
regressionswerenotedinthepatient’sskinlesions,consistent
withtheliterature.Thepatientrefusedtogothroughthorasic
surgery and died three months after presentation due to
respiratory failure.
In conclusion, there are skin lesions that accompany lung
cancer and we believe that these should be considered for
diﬀerential diagnosis.
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